Mylan has announced the launch of Ibandronic Acid Film Coated Tablets POM, 150mg, to treat osteoporosis in the UK and Italy.
The product, launched by Mylan's subsidiaries based in the UK and Italy, is the generic version of Roche's Bonviva Tablets.
Mylan CEO Heather Bresch said, "We are excited to be adding generic Ibandronic Acid to our strong portfolio of more than 350 products in the UK and 340 products in Italy, as we continue to deliver on our commitment of providing high quality and affordable medicines to patients around the world."
According to IMS Health, Ibandronic Acid Film Coated Tablets POM had sales of approximately Euro8.5m in the UK and sales of approximately Euro27m in Italy for the 12 months ending March 2012.
Source:
http://drugdiscovery.pharmaceutical-business-review.com/news/mylan-introduces-generic-osteoporosis-drug-in-uk-italy-250512
